Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Rev Esp Quimioter ; 32(2): 121-129, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30727714

RESUMO

OBJECTIVE: To evaluate, by applying pharmacokinetic/pharmacodynamic (PK/PD) analysis, if the change in antibiotic susceptibility after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Spain had any influence on the usefulness of the antimicrobials more frequently used as empirical treatment of pediatric acute otitis media (AOM). METHODS: PK parameters and susceptibility of Streptococcus pneumoniae and Haemophilus influenzae were obtained from bibliography. Monte Carlo simulation was used to estimate the cumulative fraction of response (CFR), understood as the expected probability of therapy success. For amoxicillin and amoxicillin/clavulanate, the target was free antibiotic concentration remaining above the minimum inhibitory concentration (MIC) for ≥50% of the dosing interval (fT>MIC≥50%), whereas for cefuroxime axetil and cefotaxime, the target was fT>MIC≥60%. CFR values ≥90% were considered successful. RESULTS: When all serotypes of S. pneumoniae are considered, amoxicillin and cefotaxime turned out to reach a high probability of success, and difference before and after vaccination was scarce. For H. influenzae, CFR values were higher with amoxicillin/clavulanate than with amoxicillin. For both microorganisms, cefuroxime axetil resulted in low probability of success in the two periods of study. CONCLUSIONS: We have shown that the introduction of the PCV7 vaccination did not lead to changes in the probability of success of the current empiric treatments of the AOM. Integrated PK/PD analysis has demonstrated to be a useful tool to identify changes in antimicrobial activity after the implantation of a vaccination program, providing complementary information to the simple assessment of MIC values.


Assuntos
Antibacterianos/farmacocinética , Antibacterianos/uso terapêutico , Vacina Pneumocócica Conjugada Heptavalente/uso terapêutico , Otite Média/tratamento farmacológico , Otite Média/prevenção & controle , Vacinas Estreptocócicas/uso terapêutico , Algoritmos , Amoxicilina/farmacocinética , Amoxicilina/uso terapêutico , Combinação Amoxicilina e Clavulanato de Potássio/farmacocinética , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Cefuroxima/análogos & derivados , Cefuroxima/farmacocinética , Cefuroxima/uso terapêutico , Criança , Feminino , Haemophilus influenzae/efeitos dos fármacos , Humanos , Masculino , Testes de Sensibilidade Microbiana , Método de Monte Carlo , Otite Média/microbiologia , Espanha , Streptococcus pneumoniae/efeitos dos fármacos , Resultado do Tratamento , Vacinação
3.
Eur J Clin Microbiol Infect Dis ; 31(9): 2227-35, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22371294

RESUMO

PURPOSE: To evaluate the usefulness of daptomycin, tigecycline, and linezolid for the treatment of MRSA infection compared with vancomycin in Belgium, the United Kingdom/Ireland, and Spain. METHODS: The methodology included the following steps: acquisition of microbiological and pharmacokinetic data, Monte Carlo simulation, estimation of the probability of target attainment (PTA), and calculation of the cumulative fraction of response (CFR). RESULTS: We showed that differences in the susceptibility of MRSA strains among countries may justify differences in the antibiotic dose selection. Two, 3, and 4 g daily of vancomycin seem be adequate in Belgium, Spain, and United Kingdom/Ireland respectively. The CFR obtained with 50 mg tigecycline every 12 h was higher in Spain than in Belgium and the United Kingdom/Ireland, but with the highest dose (100 mg q12h) the CFR was always 100%. At least 8 mg/kg daptomycin is necessary in United Kingdom/Ireland, but 4 mg/kg may be sufficient in Spain, and probably in Belgium. Six hundred mg q12h linezolid may be adequate in the four countries. CONCLUSION: Our study reinforces the idea that the local MIC distribution must be considered in order to increase the probability of success of empirical treatment and must be periodically updated.


Assuntos
Acetamidas/farmacocinética , Antibacterianos/farmacocinética , Daptomicina/farmacocinética , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Minociclina/análogos & derivados , Oxazolidinonas/farmacocinética , Infecções Estafilocócicas/microbiologia , Vancomicina/farmacocinética , Acetamidas/administração & dosagem , Antibacterianos/administração & dosagem , Bélgica , Daptomicina/administração & dosagem , Irlanda , Linezolida , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Testes de Sensibilidade Microbiana , Minociclina/administração & dosagem , Minociclina/farmacocinética , Oxazolidinonas/administração & dosagem , Espanha , Infecções Estafilocócicas/tratamento farmacológico , Tigeciclina , Reino Unido , Vancomicina/administração & dosagem
4.
J Chemother ; 21(4): 408-13, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19622459

RESUMO

The aim of this study was to predict the clinical efficacy of different antimicrobials in the treatment of patients with acute otitis media (AOM), before and after the change in the proportion of middle ear pathogens observed after the introduction of the new conjugated heptavalent penumococcal vaccine (pPCV-7). The therapeutic Outcomes model was used to predict the likelihood of clinical success. According to this mathematical model the obtained rank order of predicted clinical efficacy was similar in the pre-PVC7 period and the post-PVC period. The results suggest that ceftriaxone and amoxicillin/clavulanate are the antibiotics with the highest predicted clinical efficacy, whereas cefaclor, azithromycin, erythromycin and clarithromycin are those with the lowest predicted clinical efficacy. The differences between antibiotics with good and those with low antibacterial activity were greater when only cases of bacterial AOM were considered. Antibiotics for which the highest clinical efficacy was predicted should maximize the likelihood of cure in outpatient antibiotic treatment of AOM.


Assuntos
Antibacterianos/uso terapêutico , Bactérias/efeitos dos fármacos , Bactérias/patogenicidade , Infecções Bacterianas/tratamento farmacológico , Modelos Estatísticos , Otite Média/tratamento farmacológico , Otite Média/microbiologia , Doença Aguda , Bactérias/isolamento & purificação , Infecções Bacterianas/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Resultado do Tratamento
5.
Clin Chim Acta ; 302(1-2): 145-54, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11074071

RESUMO

Magnesium deficiency is a common clinical condition that may exist despite a normal serum magnesium concentration. Patients with chronic pancreatitis could develop magnesium deficiency due to either malabsorption, diabetes mellitus, or chronic alcoholism. Since serum levels of magnesium are a poor indicator of magnesium deficiency, the retention of a low-dose intravenous magnesium load (0.1 mmol/kg body weight) was determined in 13 patients with chronic pancreatitis (10 due to alcoholism) and eight healthy controls. Percentage magnesium retention was greater in patients with chronic pancreatitis than controls (59.8+/-37.3% S.D. versus 22.0+/-38.2% S. D.: P=0.038), and 10 of 13 patients showed evidence of magnesium deficiency. Routine evaluation of magnesium status could allow appropriate supplementation and conceivably symptomatic improvement in patients with severe chronic pancreatitis.


Assuntos
Deficiência de Magnésio/diagnóstico , Magnésio , Pancreatite/complicações , Adulto , Cálcio/sangue , Doença Crônica , Creatinina/sangue , Feminino , Humanos , Infusões Intravenosas , Magnésio/análise , Deficiência de Magnésio/sangue , Deficiência de Magnésio/etiologia , Masculino , Pessoa de Meia-Idade , Pancreatite/sangue , Pancreatite Alcoólica/sangue , Pancreatite Alcoólica/complicações , Albumina Sérica/análise , Sódio/sangue
6.
J Neurosurg ; 72(4): 647-9, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2319324

RESUMO

A 50-year-old man with a right hemiparesis was found to have a cavernous malformation in the left thalamus. The diagnosis was made using magnetic resonance (MR) imaging. The vascular malformation was totally removed by means of a transcallosal interhemispheric surgical approach, but the patient's neurological deficit worsened. The role of MR imaging in establishing the diagnosis is emphasized and other published cases with thalamic locations are reviewed.


Assuntos
Seio Cavernoso/anormalidades , Tálamo/irrigação sanguínea , Afasia de Broca/etiologia , Afasia de Broca/fisiopatologia , Seio Cavernoso/patologia , Seio Cavernoso/cirurgia , Hemiplegia/etiologia , Hemiplegia/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA